SI-BONE Inc.Find Ratings Reports
SI-BONE INC's gross profit margin for the first quarter of its fiscal year 2022 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. SI-BONE INC is extremely liquid. Currently, the Quick Ratio is 9.28 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
During the same period, stockholders' equity ("net worth") has decreased by 24.26% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY22||Q1 FY21|
|Net Sales ($mil)||22.44||20.44|
|Net Income ($mil)||-17.41||-12.24|
|Balance Sheet||Q1 FY22||Q1 FY21|
|Cash & Equiv. ($mil)||130.73||185.05|
|Total Assets ($mil)||176.85||215.76|
|Total Debt ($mil)||40.2||39.54|
|Profitability||Q1 FY22||Q1 FY21|
|Gross Profit Margin||86.71||90.9|
|Return on Assets||-34.91||-20.0|
|Return on Equity||-50.43||-26.7|
|Debt||Q1 FY22||Q1 FY21|
|Share Data||Q1 FY22||Q1 FY21|
|Shares outstanding (mil)||33.67||32.81|
|Div / share||0.0||0.0|
|Book value / share||3.64||4.93|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||274656.0||303065.0|
SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. For additional comparison, its price-to-book ratio of 3.31 indicates a discount versus the S&P 500 average of 3.81 and a discount versus the subsector average of 4.42. The price-to-sales ratio is well above the S&P 500 average, but well below the subsector average. After reviewing these and other key valuation criteria, SI-BONE INC proves to trade at a discount to investment alternatives.
|SIBN NM||Peers 46.15||SIBN NA||Peers 24.80|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
SIBN's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|SIBN NM||Peers 22.39||SIBN NA||Peers 1.70|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
SIBN's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|SIBN 3.31||Peers 4.42||SIBN -30.28||Peers 49.03|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
SIBN is trading at a significant discount to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, SIBN is expected to significantly trail its peers on the basis of its earnings growth rate.
|SIBN 4.40||Peers 5.13||SIBN 19.66||Peers 20.78|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
SIBN is trading at a discount to its subsector on this measurement.
Average. Comparing a company's sales growth to its subsector helps to determine if the company is adding or losing market share.
SIBN is keeping pace with its peers on the basis of sales growth.